Accelerate and Optimize Your Cell Line Development
eBook Nov 05, 2020
During the last decade, production of monoclonal antibodies (mAbs) and recombinant proteins using mammalian cells has led to a boom in the number of biotherapeutic proteins reaching the market. Key elements fueling this growth include the rising demand for effective therapeutics, production of mABs as a cancer treatment strategy and increasing vaccine production efforts.
As this growth continues, the need to reduce cell line development costs and shorten the time to market is more critical than ever.
Download this eBook to:
- Explore key cell line development steps for recombinant proteins and hybridomas
- Uncover the importance of monoclonality from a quality and regulatory perspective
- Discover solutions for various stages of cell line development
Proteomics continues to make a major impact on the discovery of fundamental biological processes, facilitating the development of diagnostic and therapeutic strategies for numerous diseases, including cancer. Download this eBook to gain a deeper understanding of the proteomic landscape.READ MORE